Do fluorescent drugs show you more than you wanted to know?
- 1 May 2003
- journal article
- editorial
- Published by Wiley in British Journal of Pharmacology
- Vol. 139 (2) , 187-189
- https://doi.org/10.1038/sj.bjp.0705288
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pharmacology and direct visualisation of BODIPY‐TMR‐CGP: a long‐acting fluorescent β2‐adrenoceptor agonistBritish Journal of Pharmacology, 2003
- Pharmacological characterization of CGP 12177 at the human β2‐adrenoceptorBritish Journal of Pharmacology, 2002
- Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferensBritish Journal of Pharmacology, 2002
- Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens: Commentary on Jackson and CunnaneBritish Journal of Pharmacology, 2002
- Pharmacological implications of cellular localization of α1‐adrenoceptors in native smooth muscle cellsJournal of Autonomic Pharmacology, 1999
- Exploring the dynamics of regulation of G protein‐coupled receptors using green fluorescent proteinBritish Journal of Pharmacology, 1999
- Importance of Agonists in α-Adrenoceptor Classification and Localisation of α1-Adrenoceptors in Human ProstateEuropean Urology, 1999
- Fluorescent ligands for the study of receptorsTrends in Pharmacological Sciences, 1996
- Exosites: their current status, and their relevance to the duration of action of long-acting β2-adrenoceptor agonistsTrends in Pharmacological Sciences, 1996
- Synthesis and Properties of Fluorescent .beta.-Adrenoceptor LigandsBiochemistry, 1994